1. Home
  2. NRC vs PEPG Comparison

NRC vs PEPG Comparison

Compare NRC & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Research Corporation (Delaware)

NRC

National Research Corporation (Delaware)

HOLD

Current Price

$14.06

Market Cap

428.2M

Sector

Health Care

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$6.46

Market Cap

440.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRC
PEPG
Founded
1981
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
428.2M
440.0M
IPO Year
1997
2022

Fundamental Metrics

Financial Performance
Metric
NRC
PEPG
Price
$14.06
$6.46
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$11.67
AVG Volume (30 Days)
128.2K
590.5K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
4.62%
N/A
EPS Growth
N/A
13.64
EPS
0.43
N/A
Revenue
$119,686,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$32.58
N/A
Revenue Growth
1.81
N/A
52 Week Low
$9.76
$0.89
52 Week High
$22.79
$7.80

Technical Indicators

Market Signals
Indicator
NRC
PEPG
Relative Strength Index (RSI) 43.33 57.25
Support Level $11.59 $4.36
Resistance Level $14.20 $6.73
Average True Range (ATR) 1.00 0.61
MACD 0.18 0.04
Stochastic Oscillator 60.99 73.78

Price Performance

Historical Comparison
NRC
PEPG

About NRC National Research Corporation (Delaware)

National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

Share on Social Networks: